The global Oral Contrast Agent market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
In terms of production side, this report researches the Oral Contrast Agent production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Oral Contrast Agent by regions (countries) and by Application.
The global Oral Contrast Agent market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Oral Contrast Agent market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Oral Contrast Agent markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Oral Contrast Agent market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Oral Contrast Agent market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Oral Contrast Agent market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Oral Contrast Agent market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Oral Contrast Agent market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Oral Contrast Agent market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Oral Contrast Agent market by each application segment for the same period.
This report includes the following manufacturers:
GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)
Jodas (India)
Magnus Health (India)
Market Segment by Type
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
Market Segment by Application
Cardiovascular Disorders
Cancer
Gastrointestinal Disorders
Musculoskeletal Disorders
Neurological Disorders
Nephrological Disorders
Research Methodology
To compile the detailed study of the global Oral Contrast Agent market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Oral Contrast Agent market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Oral Contrast Agent market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
In terms of production side, this report researches the Oral Contrast Agent production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Oral Contrast Agent by regions (countries) and by Application.
The global Oral Contrast Agent market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Oral Contrast Agent market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Oral Contrast Agent markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Oral Contrast Agent market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Oral Contrast Agent market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Oral Contrast Agent market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Oral Contrast Agent market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Oral Contrast Agent market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Oral Contrast Agent market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Oral Contrast Agent market by each application segment for the same period.
This report includes the following manufacturers:
GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)
Jodas (India)
Magnus Health (India)
Market Segment by Type
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
Market Segment by Application
Cardiovascular Disorders
Cancer
Gastrointestinal Disorders
Musculoskeletal Disorders
Neurological Disorders
Nephrological Disorders
Research Methodology
To compile the detailed study of the global Oral Contrast Agent market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Oral Contrast Agent market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Oral Contrast Agent market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Oral Contrast Agent Market Size Growth Rate by Type
1.2.2 Barium-based Contrast Media
1.2.3 Iodinated Contrast Media
1.2.4 Gadolinium-based Contrast Media
1.2.5 Microbubble Contrast Media
1.3 Market Segment by Application
1.3.1 Global Oral Contrast Agent Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Cardiovascular Disorders
1.3.3 Cancer
1.3.4 Gastrointestinal Disorders
1.3.5 Musculoskeletal Disorders
1.3.6 Neurological Disorders
1.3.7 Nephrological Disorders
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Oral Contrast Agent Market Size (2016-2027)
2.1.1 Global Oral Contrast Agent Revenue (2016-2027)
2.1.2 Global Oral Contrast Agent Sales (2016-2027)
2.2 Global Oral Contrast Agent Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Oral Contrast Agent Sales by Regions (2016-2021)
2.2.2 Global Oral Contrast Agent Revenue by Regions (2016-2021)
2.3 Global Oral Contrast Agent Market Size Forecast by Region
2.3.1 Global Oral Contrast Agent Sales Forecast by Region (2022-2027)
2.3.2 Global Oral Contrast Agent Revenue Forecast by Region (2022-2027)
2.4 Global Top Oral Contrast Agent Regions (Countries) Ranking by Market Size
2.5 Oral Contrast Agent Industry Trends
2.5.1 Oral Contrast Agent Market Trends
2.5.2 Oral Contrast Agent Market Drivers
2.5.3 Oral Contrast Agent Market Challenges
2.5.4 Oral Contrast Agent Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Oral Contrast Agent Manufacturers by Sales (2016-2021)
3.1.1 Global Oral Contrast Agent Sales by Manufacturers (2016-2021)
3.1.2 Global Oral Contrast Agent Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Oral Contrast Agent Sales in 2020
3.2 Global Top Manufacturers Oral Contrast Agent by Revenue
3.2.1 Global Oral Contrast Agent Revenue by Manufacturers (2016-2021)
3.2.2 Top Oral Contrast Agent Manufacturers Covered: Ranking by Revenue
3.2.3 Global Oral Contrast Agent Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Oral Contrast Agent Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Contrast Agent as of 2020)
3.4 Global Oral Contrast Agent Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Oral Contrast Agent Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Oral Contrast Agent Market
3.7 Key Manufacturers Oral Contrast Agent Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Oral Contrast Agent Market Size by Type
4.1 Global Oral Contrast Agent Historic Market Review by Type (2016-2021)
4.1.1 Global Oral Contrast Agent Sales Market Share by Type (2016-2021)
4.1.2 Global Oral Contrast Agent Revenue Market Share by Type (2016-2021)
4.1.3 Oral Contrast Agent Price by Type (2016-2021)
4.2 Global Oral Contrast Agent Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Oral Contrast Agent Sales Forecast by Type (2022-2027)
4.2.2 Global Oral Contrast Agent Revenue Forecast by Type (2022-2027)
4.2.3 Oral Contrast Agent Price Forecast by Type (2022-2027)
5 Global Oral Contrast Agent Market Size by Application
5.1 Global Oral Contrast Agent Historic Market Review by Application (2016-2021)
5.1.1 Global Oral Contrast Agent Sales Market Share by Application (2016-2021)
5.1.2 Global Oral Contrast Agent Revenue Market Share by Application (2016-2021)
5.1.3 Oral Contrast Agent Price by Application (2016-2021)
5.2 Global Oral Contrast Agent Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Oral Contrast Agent Sales Forecast by Application (2022-2027)
5.2.2 Global Oral Contrast Agent Revenue Forecast by Application (2022-2027)
5.2.3 Oral Contrast Agent Price Forecast by Application (2022-2027)
6 North America
6.1 North America Oral Contrast Agent Sales Breakdown by Company
6.1.1 North America Oral Contrast Agent Sales by Company (2016-2027)
6.1.2 North America Oral Contrast Agent Revenue by Company (2016-2027)
6.2 North America Oral Contrast Agent Market Size by Type (2016-2027)
6.2.1 North America Oral Contrast Agent Sales by Type (2016-2027)
6.2.2 North America Oral Contrast Agent Revenue by Type (2016-2027)
6.3 North America Oral Contrast Agent Market Size by Application (2016-2027)
6.3.1 North America Oral Contrast Agent Sales by Application (2016-2027)
6.3.2 North America Oral Contrast Agent Revenue by Application (2016-2027)
6.4 North America Oral Contrast Agent Market Size by Country
6.4.1 North America Oral Contrast Agent Sales by Country (2016-2027)
6.4.2 North America Oral Contrast Agent Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Oral Contrast Agent Sales Breakdown by Company
7.1.1 Europe Oral Contrast Agent Sales by Company (2016-2027)
7.1.2 Europe Oral Contrast Agent Revenue by Company (2016-2027)
7.2 Europe Oral Contrast Agent Market Size by Type (2016-2027)
7.2.1 Europe Oral Contrast Agent Sales by Type (2016-2027)
7.2.2 Europe Oral Contrast Agent Revenue by Type (2016-2027)
7.3 Europe Oral Contrast Agent Market Size by Application (2016-2027)
7.3.1 Europe Oral Contrast Agent Sales by Application (2016-2027)
7.3.2 Europe Oral Contrast Agent Revenue by Application (2016-2027)
7.4 Europe Oral Contrast Agent Market Size by Country
7.4.1 Europe Oral Contrast Agent Sales by Country (2016-2027)
7.4.2 Europe Oral Contrast Agent Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oral Contrast Agent Sales Breakdown by Company
8.1.1 Asia Pacific Oral Contrast Agent Sales by Company (2016-2027)
8.1.2 Asia Pacific Oral Contrast Agent Revenue by Company (2016-2027)
8.2 Asia Pacific Oral Contrast Agent Market Size by Type (2016-2027)
8.2.1 Asia Pacific Oral Contrast Agent Sales by Type (2016-2027)
8.2.2 Asia Pacific Oral Contrast Agent Revenue by Type (2016-2027)
8.3 Asia Pacific Oral Contrast Agent Market Size by Application (2016-2027)
8.3.1 Asia Pacific Oral Contrast Agent Sales by Application (2016-2027)
8.3.2 Asia Pacific Oral Contrast Agent Revenue by Application (2016-2027)
8.4 Asia Pacific Oral Contrast Agent Market Size by Regions
8.4.1 Asia Pacific Oral Contrast Agent Sales by Regions
8.4.2 Asia Pacific Oral Contrast Agent Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Oral Contrast Agent Sales Breakdown by Company
9.1.1 Latin America Oral Contrast Agent Sales by Company (2016-2027)
9.1.2 Latin America Oral Contrast Agent Revenue by Company (2016-2027)
9.2 Latin America Oral Contrast Agent Market Size by Type (2016-2027)
9.2.1 Latin America Oral Contrast Agent Sales by Type (2016-2027)
9.2.2 Latin America Oral Contrast Agent Revenue by Type (2016-2027)
9.3 Latin America Oral Contrast Agent Market Size by Application (2016-2027)
9.3.1 Latin America Oral Contrast Agent Sales by Application (2016-2027)
9.3.2 Latin America Oral Contrast Agent Revenue by Application (2016-2027)
9.4 Latin America Oral Contrast Agent Market Size by Country
9.4.1 Latin America Oral Contrast Agent Sales by Country (2016-2027)
9.4.2 Latin America Oral Contrast Agent Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Oral Contrast Agent Sales Breakdown by Company
10.1.1 Middle East and Africa Oral Contrast Agent Sales by Company (2016-2027)
10.1.2 Middle East and Africa Oral Contrast Agent Revenue by Company (2016-2027)
10.2 Middle East and Africa Oral Contrast Agent Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Oral Contrast Agent Sales by Type (2016-2027)
10.2.2 Middle East and Africa Oral Contrast Agent Revenue by Type (2016-2027)
10.3 Middle East and Africa Oral Contrast Agent Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Oral Contrast Agent Sales by Application (2016-2027)
10.3.2 Middle East and Africa Oral Contrast Agent Revenue by Application (2016-2027)
10.4 Middle East and Africa Oral Contrast Agent Market Size by Country
10.4.1 Middle East and Africa Oral Contrast Agent Sales by Country (2016-2027)
10.4.2 Middle East and Africa Oral Contrast Agent Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 GE Healthcare (US)
11.1.1 GE Healthcare (US) Corporation Information
11.1.2 GE Healthcare (US) Overview
11.1.3 GE Healthcare (US) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 GE Healthcare (US) Oral Contrast Agent Products and Services
11.1.5 GE Healthcare (US) Oral Contrast Agent SWOT Analysis
11.1.6 GE Healthcare (US) Recent Developments
11.2 Bracco Imaging (Italy)
11.2.1 Bracco Imaging (Italy) Corporation Information
11.2.2 Bracco Imaging (Italy) Overview
11.2.3 Bracco Imaging (Italy) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Bracco Imaging (Italy) Oral Contrast Agent Products and Services
11.2.5 Bracco Imaging (Italy) Oral Contrast Agent SWOT Analysis
11.2.6 Bracco Imaging (Italy) Recent Developments
11.3 Bayer HealthCare (Germany)
11.3.1 Bayer HealthCare (Germany) Corporation Information
11.3.2 Bayer HealthCare (Germany) Overview
11.3.3 Bayer HealthCare (Germany) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Bayer HealthCare (Germany) Oral Contrast Agent Products and Services
11.3.5 Bayer HealthCare (Germany) Oral Contrast Agent SWOT Analysis
11.3.6 Bayer HealthCare (Germany) Recent Developments
11.4 Guerbet (France)
11.4.1 Guerbet (France) Corporation Information
11.4.2 Guerbet (France) Overview
11.4.3 Guerbet (France) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Guerbet (France) Oral Contrast Agent Products and Services
11.4.5 Guerbet (France) Oral Contrast Agent SWOT Analysis
11.4.6 Guerbet (France) Recent Developments
11.5 Lantheus (US)
11.5.1 Lantheus (US) Corporation Information
11.5.2 Lantheus (US) Overview
11.5.3 Lantheus (US) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 Lantheus (US) Oral Contrast Agent Products and Services
11.5.5 Lantheus (US) Oral Contrast Agent SWOT Analysis
11.5.6 Lantheus (US) Recent Developments
11.6 Daiichi Sankyo (Japan)
11.6.1 Daiichi Sankyo (Japan) Corporation Information
11.6.2 Daiichi Sankyo (Japan) Overview
11.6.3 Daiichi Sankyo (Japan) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Daiichi Sankyo (Japan) Oral Contrast Agent Products and Services
11.6.5 Daiichi Sankyo (Japan) Oral Contrast Agent SWOT Analysis
11.6.6 Daiichi Sankyo (Japan) Recent Developments
11.7 Unijules Life Sciences (India)
11.7.1 Unijules Life Sciences (India) Corporation Information
11.7.2 Unijules Life Sciences (India) Overview
11.7.3 Unijules Life Sciences (India) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 Unijules Life Sciences (India) Oral Contrast Agent Products and Services
11.7.5 Unijules Life Sciences (India) Oral Contrast Agent SWOT Analysis
11.7.6 Unijules Life Sciences (India) Recent Developments
11.8 J.B. Chemicals and Pharmaceuticals (India)
11.8.1 J.B. Chemicals and Pharmaceuticals (India) Corporation Information
11.8.2 J.B. Chemicals and Pharmaceuticals (India) Overview
11.8.3 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Products and Services
11.8.5 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent SWOT Analysis
11.8.6 J.B. Chemicals and Pharmaceuticals (India) Recent Developments
11.9 Spago Nanomedicine (Sweden)
11.9.1 Spago Nanomedicine (Sweden) Corporation Information
11.9.2 Spago Nanomedicine (Sweden) Overview
11.9.3 Spago Nanomedicine (Sweden) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 Spago Nanomedicine (Sweden) Oral Contrast Agent Products and Services
11.9.5 Spago Nanomedicine (Sweden) Oral Contrast Agent SWOT Analysis
11.9.6 Spago Nanomedicine (Sweden) Recent Developments
11.10 Taejoon Pharm (South Korea)
11.10.1 Taejoon Pharm (South Korea) Corporation Information
11.10.2 Taejoon Pharm (South Korea) Overview
11.10.3 Taejoon Pharm (South Korea) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 Taejoon Pharm (South Korea) Oral Contrast Agent Products and Services
11.10.5 Taejoon Pharm (South Korea) Oral Contrast Agent SWOT Analysis
11.10.6 Taejoon Pharm (South Korea) Recent Developments
11.11 Jodas (India)
11.11.1 Jodas (India) Corporation Information
11.11.2 Jodas (India) Overview
11.11.3 Jodas (India) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.11.4 Jodas (India) Oral Contrast Agent Products and Services
11.11.5 Jodas (India) Recent Developments
11.12 Magnus Health (India)
11.12.1 Magnus Health (India) Corporation Information
11.12.2 Magnus Health (India) Overview
11.12.3 Magnus Health (India) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.12.4 Magnus Health (India) Oral Contrast Agent Products and Services
11.12.5 Magnus Health (India) Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Oral Contrast Agent Value Chain Analysis
12.2 Oral Contrast Agent Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oral Contrast Agent Production Mode & Process
12.4 Oral Contrast Agent Sales and Marketing
12.4.1 Oral Contrast Agent Sales Channels
12.4.2 Oral Contrast Agent Distributors
12.5 Oral Contrast Agent Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Oral Contrast Agent Market Size Growth Rate by Type
1.2.2 Barium-based Contrast Media
1.2.3 Iodinated Contrast Media
1.2.4 Gadolinium-based Contrast Media
1.2.5 Microbubble Contrast Media
1.3 Market Segment by Application
1.3.1 Global Oral Contrast Agent Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Cardiovascular Disorders
1.3.3 Cancer
1.3.4 Gastrointestinal Disorders
1.3.5 Musculoskeletal Disorders
1.3.6 Neurological Disorders
1.3.7 Nephrological Disorders
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Oral Contrast Agent Market Size (2016-2027)
2.1.1 Global Oral Contrast Agent Revenue (2016-2027)
2.1.2 Global Oral Contrast Agent Sales (2016-2027)
2.2 Global Oral Contrast Agent Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Oral Contrast Agent Sales by Regions (2016-2021)
2.2.2 Global Oral Contrast Agent Revenue by Regions (2016-2021)
2.3 Global Oral Contrast Agent Market Size Forecast by Region
2.3.1 Global Oral Contrast Agent Sales Forecast by Region (2022-2027)
2.3.2 Global Oral Contrast Agent Revenue Forecast by Region (2022-2027)
2.4 Global Top Oral Contrast Agent Regions (Countries) Ranking by Market Size
2.5 Oral Contrast Agent Industry Trends
2.5.1 Oral Contrast Agent Market Trends
2.5.2 Oral Contrast Agent Market Drivers
2.5.3 Oral Contrast Agent Market Challenges
2.5.4 Oral Contrast Agent Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Oral Contrast Agent Manufacturers by Sales (2016-2021)
3.1.1 Global Oral Contrast Agent Sales by Manufacturers (2016-2021)
3.1.2 Global Oral Contrast Agent Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Oral Contrast Agent Sales in 2020
3.2 Global Top Manufacturers Oral Contrast Agent by Revenue
3.2.1 Global Oral Contrast Agent Revenue by Manufacturers (2016-2021)
3.2.2 Top Oral Contrast Agent Manufacturers Covered: Ranking by Revenue
3.2.3 Global Oral Contrast Agent Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Oral Contrast Agent Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Contrast Agent as of 2020)
3.4 Global Oral Contrast Agent Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Oral Contrast Agent Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Oral Contrast Agent Market
3.7 Key Manufacturers Oral Contrast Agent Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Oral Contrast Agent Market Size by Type
4.1 Global Oral Contrast Agent Historic Market Review by Type (2016-2021)
4.1.1 Global Oral Contrast Agent Sales Market Share by Type (2016-2021)
4.1.2 Global Oral Contrast Agent Revenue Market Share by Type (2016-2021)
4.1.3 Oral Contrast Agent Price by Type (2016-2021)
4.2 Global Oral Contrast Agent Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Oral Contrast Agent Sales Forecast by Type (2022-2027)
4.2.2 Global Oral Contrast Agent Revenue Forecast by Type (2022-2027)
4.2.3 Oral Contrast Agent Price Forecast by Type (2022-2027)
5 Global Oral Contrast Agent Market Size by Application
5.1 Global Oral Contrast Agent Historic Market Review by Application (2016-2021)
5.1.1 Global Oral Contrast Agent Sales Market Share by Application (2016-2021)
5.1.2 Global Oral Contrast Agent Revenue Market Share by Application (2016-2021)
5.1.3 Oral Contrast Agent Price by Application (2016-2021)
5.2 Global Oral Contrast Agent Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Oral Contrast Agent Sales Forecast by Application (2022-2027)
5.2.2 Global Oral Contrast Agent Revenue Forecast by Application (2022-2027)
5.2.3 Oral Contrast Agent Price Forecast by Application (2022-2027)
6 North America
6.1 North America Oral Contrast Agent Sales Breakdown by Company
6.1.1 North America Oral Contrast Agent Sales by Company (2016-2027)
6.1.2 North America Oral Contrast Agent Revenue by Company (2016-2027)
6.2 North America Oral Contrast Agent Market Size by Type (2016-2027)
6.2.1 North America Oral Contrast Agent Sales by Type (2016-2027)
6.2.2 North America Oral Contrast Agent Revenue by Type (2016-2027)
6.3 North America Oral Contrast Agent Market Size by Application (2016-2027)
6.3.1 North America Oral Contrast Agent Sales by Application (2016-2027)
6.3.2 North America Oral Contrast Agent Revenue by Application (2016-2027)
6.4 North America Oral Contrast Agent Market Size by Country
6.4.1 North America Oral Contrast Agent Sales by Country (2016-2027)
6.4.2 North America Oral Contrast Agent Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Oral Contrast Agent Sales Breakdown by Company
7.1.1 Europe Oral Contrast Agent Sales by Company (2016-2027)
7.1.2 Europe Oral Contrast Agent Revenue by Company (2016-2027)
7.2 Europe Oral Contrast Agent Market Size by Type (2016-2027)
7.2.1 Europe Oral Contrast Agent Sales by Type (2016-2027)
7.2.2 Europe Oral Contrast Agent Revenue by Type (2016-2027)
7.3 Europe Oral Contrast Agent Market Size by Application (2016-2027)
7.3.1 Europe Oral Contrast Agent Sales by Application (2016-2027)
7.3.2 Europe Oral Contrast Agent Revenue by Application (2016-2027)
7.4 Europe Oral Contrast Agent Market Size by Country
7.4.1 Europe Oral Contrast Agent Sales by Country (2016-2027)
7.4.2 Europe Oral Contrast Agent Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oral Contrast Agent Sales Breakdown by Company
8.1.1 Asia Pacific Oral Contrast Agent Sales by Company (2016-2027)
8.1.2 Asia Pacific Oral Contrast Agent Revenue by Company (2016-2027)
8.2 Asia Pacific Oral Contrast Agent Market Size by Type (2016-2027)
8.2.1 Asia Pacific Oral Contrast Agent Sales by Type (2016-2027)
8.2.2 Asia Pacific Oral Contrast Agent Revenue by Type (2016-2027)
8.3 Asia Pacific Oral Contrast Agent Market Size by Application (2016-2027)
8.3.1 Asia Pacific Oral Contrast Agent Sales by Application (2016-2027)
8.3.2 Asia Pacific Oral Contrast Agent Revenue by Application (2016-2027)
8.4 Asia Pacific Oral Contrast Agent Market Size by Regions
8.4.1 Asia Pacific Oral Contrast Agent Sales by Regions
8.4.2 Asia Pacific Oral Contrast Agent Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Oral Contrast Agent Sales Breakdown by Company
9.1.1 Latin America Oral Contrast Agent Sales by Company (2016-2027)
9.1.2 Latin America Oral Contrast Agent Revenue by Company (2016-2027)
9.2 Latin America Oral Contrast Agent Market Size by Type (2016-2027)
9.2.1 Latin America Oral Contrast Agent Sales by Type (2016-2027)
9.2.2 Latin America Oral Contrast Agent Revenue by Type (2016-2027)
9.3 Latin America Oral Contrast Agent Market Size by Application (2016-2027)
9.3.1 Latin America Oral Contrast Agent Sales by Application (2016-2027)
9.3.2 Latin America Oral Contrast Agent Revenue by Application (2016-2027)
9.4 Latin America Oral Contrast Agent Market Size by Country
9.4.1 Latin America Oral Contrast Agent Sales by Country (2016-2027)
9.4.2 Latin America Oral Contrast Agent Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Oral Contrast Agent Sales Breakdown by Company
10.1.1 Middle East and Africa Oral Contrast Agent Sales by Company (2016-2027)
10.1.2 Middle East and Africa Oral Contrast Agent Revenue by Company (2016-2027)
10.2 Middle East and Africa Oral Contrast Agent Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Oral Contrast Agent Sales by Type (2016-2027)
10.2.2 Middle East and Africa Oral Contrast Agent Revenue by Type (2016-2027)
10.3 Middle East and Africa Oral Contrast Agent Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Oral Contrast Agent Sales by Application (2016-2027)
10.3.2 Middle East and Africa Oral Contrast Agent Revenue by Application (2016-2027)
10.4 Middle East and Africa Oral Contrast Agent Market Size by Country
10.4.1 Middle East and Africa Oral Contrast Agent Sales by Country (2016-2027)
10.4.2 Middle East and Africa Oral Contrast Agent Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 GE Healthcare (US)
11.1.1 GE Healthcare (US) Corporation Information
11.1.2 GE Healthcare (US) Overview
11.1.3 GE Healthcare (US) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 GE Healthcare (US) Oral Contrast Agent Products and Services
11.1.5 GE Healthcare (US) Oral Contrast Agent SWOT Analysis
11.1.6 GE Healthcare (US) Recent Developments
11.2 Bracco Imaging (Italy)
11.2.1 Bracco Imaging (Italy) Corporation Information
11.2.2 Bracco Imaging (Italy) Overview
11.2.3 Bracco Imaging (Italy) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Bracco Imaging (Italy) Oral Contrast Agent Products and Services
11.2.5 Bracco Imaging (Italy) Oral Contrast Agent SWOT Analysis
11.2.6 Bracco Imaging (Italy) Recent Developments
11.3 Bayer HealthCare (Germany)
11.3.1 Bayer HealthCare (Germany) Corporation Information
11.3.2 Bayer HealthCare (Germany) Overview
11.3.3 Bayer HealthCare (Germany) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Bayer HealthCare (Germany) Oral Contrast Agent Products and Services
11.3.5 Bayer HealthCare (Germany) Oral Contrast Agent SWOT Analysis
11.3.6 Bayer HealthCare (Germany) Recent Developments
11.4 Guerbet (France)
11.4.1 Guerbet (France) Corporation Information
11.4.2 Guerbet (France) Overview
11.4.3 Guerbet (France) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Guerbet (France) Oral Contrast Agent Products and Services
11.4.5 Guerbet (France) Oral Contrast Agent SWOT Analysis
11.4.6 Guerbet (France) Recent Developments
11.5 Lantheus (US)
11.5.1 Lantheus (US) Corporation Information
11.5.2 Lantheus (US) Overview
11.5.3 Lantheus (US) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 Lantheus (US) Oral Contrast Agent Products and Services
11.5.5 Lantheus (US) Oral Contrast Agent SWOT Analysis
11.5.6 Lantheus (US) Recent Developments
11.6 Daiichi Sankyo (Japan)
11.6.1 Daiichi Sankyo (Japan) Corporation Information
11.6.2 Daiichi Sankyo (Japan) Overview
11.6.3 Daiichi Sankyo (Japan) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Daiichi Sankyo (Japan) Oral Contrast Agent Products and Services
11.6.5 Daiichi Sankyo (Japan) Oral Contrast Agent SWOT Analysis
11.6.6 Daiichi Sankyo (Japan) Recent Developments
11.7 Unijules Life Sciences (India)
11.7.1 Unijules Life Sciences (India) Corporation Information
11.7.2 Unijules Life Sciences (India) Overview
11.7.3 Unijules Life Sciences (India) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 Unijules Life Sciences (India) Oral Contrast Agent Products and Services
11.7.5 Unijules Life Sciences (India) Oral Contrast Agent SWOT Analysis
11.7.6 Unijules Life Sciences (India) Recent Developments
11.8 J.B. Chemicals and Pharmaceuticals (India)
11.8.1 J.B. Chemicals and Pharmaceuticals (India) Corporation Information
11.8.2 J.B. Chemicals and Pharmaceuticals (India) Overview
11.8.3 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Products and Services
11.8.5 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent SWOT Analysis
11.8.6 J.B. Chemicals and Pharmaceuticals (India) Recent Developments
11.9 Spago Nanomedicine (Sweden)
11.9.1 Spago Nanomedicine (Sweden) Corporation Information
11.9.2 Spago Nanomedicine (Sweden) Overview
11.9.3 Spago Nanomedicine (Sweden) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 Spago Nanomedicine (Sweden) Oral Contrast Agent Products and Services
11.9.5 Spago Nanomedicine (Sweden) Oral Contrast Agent SWOT Analysis
11.9.6 Spago Nanomedicine (Sweden) Recent Developments
11.10 Taejoon Pharm (South Korea)
11.10.1 Taejoon Pharm (South Korea) Corporation Information
11.10.2 Taejoon Pharm (South Korea) Overview
11.10.3 Taejoon Pharm (South Korea) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 Taejoon Pharm (South Korea) Oral Contrast Agent Products and Services
11.10.5 Taejoon Pharm (South Korea) Oral Contrast Agent SWOT Analysis
11.10.6 Taejoon Pharm (South Korea) Recent Developments
11.11 Jodas (India)
11.11.1 Jodas (India) Corporation Information
11.11.2 Jodas (India) Overview
11.11.3 Jodas (India) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.11.4 Jodas (India) Oral Contrast Agent Products and Services
11.11.5 Jodas (India) Recent Developments
11.12 Magnus Health (India)
11.12.1 Magnus Health (India) Corporation Information
11.12.2 Magnus Health (India) Overview
11.12.3 Magnus Health (India) Oral Contrast Agent Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.12.4 Magnus Health (India) Oral Contrast Agent Products and Services
11.12.5 Magnus Health (India) Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Oral Contrast Agent Value Chain Analysis
12.2 Oral Contrast Agent Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oral Contrast Agent Production Mode & Process
12.4 Oral Contrast Agent Sales and Marketing
12.4.1 Oral Contrast Agent Sales Channels
12.4.2 Oral Contrast Agent Distributors
12.5 Oral Contrast Agent Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
